What is BioPharma Buffers Market Scope?
A buffer solution hereby consists of a weak conjugate acid-base pair. For example, weak acid and its conjugate base, or a weak base and its conjugate acid. Small amounts of other acids or bases will be neutralized when added to the solution, and as a result, the solution will withstand changes in pH. Stable pH solutions are mandatory for processing protein-based biological APIs due to their sensitivity to changes in pH. The stable pH range and the stable capacity (the amount of acid/base that can be added without changing the pH) of a buffer are determined by the conjugate acid-base pair. With the slowdown in global economic growth, the BioPharma buffer industry has also suffered some impact but has remained relatively optimistic for the past four years.
The BioPharma Buffers market study is being classified by Type (Phosphates, Acetates, TRIS and Others), by Application (Research Institution, Pharmaceutical Industry and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global BioPharma Buffers market throughout the predicted period.
Avantor (United States), Alfa Aesar (Thermo Fisher) (United States), Merck & Co. (United States), Lonza Group AG (Switzerland), Bio-Rad Laboratories (United States), BD (United States), GE Healthcare (United States), Promega Corporation (United States), Hamilton Company (United States) and XZL BIO-TECHNOLOGY (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sisco Research Laboratories Private Limited (India) and Biopharm International (United States).
Segmentation Analysis
Analyst at AMA have segmented the market study of Global BioPharma Buffers market by Type, Application and Region.
On the basis of geography, the market of BioPharma Buffers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Avantor has developed J.T.Baker® and Macron Fine Chemicals ™ branded buffer salts. These buffer salts are made using cGMP processes and maximize the stability of the biopharmaceutical formulations by providing predictable pH control.
Influencing Market Trend
- Growing research and development activities for the finding the newer vaccines
Market Drivers
- Growing demand for blood and blood plasma for transfusion purposes
- Ongoing research activities in the gene therapy and cell therapy fields
Opportunities
- Global ongoing vaccination program against polio, rubella and other such diseases
Restraints
- Concerns related to toxicity of certain buffer solutions
Challenges
- Highly competitive nature of the market
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, BioPharma Buffers Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.